
Top Research Reports for Eli Lilly, Linde & Caterpillar

You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Wednesday, April 17, 2024
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Co. (LLY), Linde plc (LIN) and Caterpillar Inc. (CAT). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Eli Lilly's shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the past year (+101.8% vs. +15.6%). The Zacks analyst believes that a solid portfolio of drugs for cancer, diabetes and autoimmune diseases and a solid pipeline for drugs in the area of obesity and Alzheimer’s have been helping the company’s growth.
Yet, generic competition for some drugs, rising pricing pressure and challenges in meeting strong demand for incretin products like Trulicity are some top-line headwinds.
(You can read the full research report on Eli Lilly here >>>)
Linde’s shares have outperformed the Zacks Chemical – Specialty industry over the last six months (+20.0% vs. -7.9%). The Zacks analyst believes that stable cash flows arising out of long-term contracts with on-site customers and a substantial backlog have ensured that the company’s earning potential keeps climbing.
However, rising competition for new projects in emerging markets remains a concern. The decrease in U.S. industrial production is also expected to reduce the demand for industrial gases, affecting profits.
(You can read the full research report on Linde here >>>)
Shares of Caterpillar have outperformed the Zacks Manufacturing – Construction and Mining industry over the past year (+59.8% vs. +57.2%). Per the Zacks analyst, the company’s cost-saving actions, strong end-market demand and pricing moves have offset the impact of the supply-chain interruptions and cost pressures. Rising global construction activity has also been a major tailwind.
Yet, slowdown of the Chinese real estate sector and higher cost of materials remain concerns.
(You can read the full research report on Caterpillar here >>>)
Other noteworthy reports we are featuring today include Salesforce, Inc. (CRM), Wells Fargo & Co. (WFC) and Arista Networks, Inc. (ANET).
Mark Vickery
Senior Editor
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Get the latest research report on WFC - FREE
Get the latest research report on CRM - FREE
Get the latest research report on CAT - FREE
Get the latest research report on LLY - FREE
Get the latest research report on LIN - FREE
Get the latest research report on ANET - FREE